Breaking News Instant updates and real-time market news.

2020-05-04 10:17:09 $NSD NASDAQ Market Internals $0.00 / + (+0.00%) 10:17 05/04/20 05/04 10:17 05/04/20 10:17	NASDAQ market internals summary Volume is above average for this time of day. Breadth is mixed with issues bearish while volume and new highs to new lows are bullish. Advancing Issues: 1147 / Declining Issues: 1732 -- for a ratio of 0.7 to 1. Advancing Volume: 380,617,000 / Declining Volume: 256,844,000 -- for a ratio of 1.5 to 1. New 52-Week Highs: 10 / New 52-Week Lows: 9.

2020-05-04 10:17:09

$NSD

NASDAQ Market Internals

$0.00 / + (+0.00%)

10:17

05/04/20

05/04

10:17

05/04/20

10:17

NASDAQ market internals summary

Volume is above average for this time of day. Breadth is mixed with issues bearish while volume and new highs to new lows are bullish. Advancing Issues: 1147 / Declining Issues: 1732 -- for a ratio of 0.7 to 1. Advancing Volume: 380,617,000 / Declining Volume: 256,844,000 -- for a ratio of 1.5 to 1. New 52-Week Highs: 10 / New 52-Week Lows: 9.

TODAY'S FREE FLY STORIES

Hot Stocks	Bristol-Myers receives EC approval for opdivo-cabometyx combination » 16:17 04/14/21 04/14 16:17 04/14/21 16:17 BMY Bristol-Myers $63.82 / +0.22 (+0.35%) Bristol Myers Squibb… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options BMY Bristol-Myers $63.82 / +0.22 (+0.35%) 04/11/21 Bristol-Myers announces results from CheckMate -816 study 04/08/21 Bristol-Myers reports 'positive' results from Phase 3 CheckMate -648 trial 04/01/21 Agios Pharmaceuticals enters agreement to repurchase stock from Bristol-Myers 03/30/21 Huyabio International enters clinical collaboration agreement with Bristol-Myers BMY Bristol-Myers $63.82 / +0.22 (+0.35%) 04/13/21 Truist Bristol-Myers upgraded to Buy at Truist on improving pipeline asset visibility 04/13/21 Truist Bristol-Myers upgraded to Buy from Hold at Truist 04/12/21 B. Riley B. Riley calls Agenus the next Seagen, reiterates $8 target 03/08/21 BofA Gartner added to US 1 List, Bristol-Myers removed at BofA BMY Bristol-Myers $63.82 / +0.22 (+0.35%) 03/04/21 Repare Therapeutics reports Q4 EPS ($2.66), consensus (39c) 02/24/21 CytomX Therapeutics reports Q4 revenue $16.4M, consensus $15.4M 02/04/21 Bristol-Myers boosts FY21 adjusted EPS view to $7.35-$7.55 from $7.15-$7.45 02/04/21 Bristol-Myers reports Q4 adjusted EPS $1.46, consensus $1.41 BMY Bristol-Myers $63.82 / +0.22 (+0.35%) 04/01/21 Accidental disclosure show Bristol-Myers, I.R.S. $1B tax fight, NY Times reports 02/15/21 Bristol-Myers, Sanofi to pay $834M over Plavix, Bloomberg reports 12/23/20 Judge rules against White House drug pricing rule, Reuters says 11/23/20 EU seeks easier access to generic medicines, Reuters says BMY Bristol-Myers $63.82 / +0.22 (+0.35%) 04/13/21 FedEx, Booking Holdings upgrades among today's top calls on Wall Street 03/29/21 Fly Intel: Pre-market Movers 02/09/21 Fly Intel: Pre-market Movers 12/26/20 Week in review: How Trump's policies moved stocks 04/29/21 Bristol-Myers - BMY 04/29/21 Oncologic Drugs Advisory Committee Virtual Meeting 05/20/21 PDUFA Date for CM-577 - Opdivo 05/25/21 PDUFA Date for CM-649 Opdivo+ Yervoy or Chemo 05/30/21 PDUFA Date for Zeposia (Ozanimod) 01/28/22 PDUFA Date for Mavacamten 05/04/21 Bristol Myers Squibb Co BMY Bristol-Myers $63.82 / +0.22 (+0.35%) 04/07/21 Unusually active option classes on open April 7th 01/20/21 Unusually active option classes on open January 20th 01/11/21 Unusually active option classes on open January 11th 01/05/21 Bristol Myers Squibb call volume above normal and directionally bullish
Hot Stocks	Costco increases quarterly cash dividend to 79c per share » 16:17 04/14/21 04/14 16:17 04/14/21 16:17 COST Costco $363.11 / -2.14 (-0.59%) Costco announced that its… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options COST Costco $363.11 / -2.14 (-0.59%) 04/07/21 Costco March SSS ex-impac from gas F/X up 11.1% 02/03/21 Costco reports January SSS rose 15.9% 01/06/21 Costco December SSS, ex impact from gas, FX rose 10.9% 01/06/21 Costco December E-commerce sales ex gas, FX up 61.6% COST Costco $363.11 / -2.14 (-0.59%) 04/08/21 DA Davidson Costco March sales data 'very strong', says DA Davidson 04/08/21 Oppenheimer Costco price target raised to $400 from $370 at Oppenheimer 04/08/21 Wells Fargo Costco price target raised to $400 from $370 at Wells Fargo 04/08/21 Stifel Costco price target raised to $385 from $370 at Stifel COST Costco $363.11 / -2.14 (-0.59%) 03/04/21 Costco reports Q2 EPS $2,14, consensus $2.44 03/04/21 Notable companies reporting after market close 12/10/20 Costco reports Q1 total company comparable sales up 15.4% 12/10/20 Costco reports Q1 EPS $2.62, consensus $2.05 COST Costco $363.11 / -2.14 (-0.59%) 02/26/21 Costco to hike minimum hourly wage to $16 an hour, WSJ reports 12/15/20 FedEx, UPS limiting packages they pick up, creating backlogs, WSJ reports COST Costco $363.11 / -2.14 (-0.59%) 03/11/21 Tesla initiation, GE downgrade among today's top calls on Wall Street 03/05/21 Fly Intel: Wall Street's top stories for Friday 03/05/21 Fly Intel: Wall Street's top stories at midday 03/05/21 Fly Intel: Pre-market Movers 05/27/21 Costco - COST COST Costco $363.11 / -2.14 (-0.59%) 12/10/20 Costco options imply 3.8% move in share price post-earnings 11/17/20 Early notable gainers among liquid option names on November 17th
Conference/Events	Jazz Pharmaceuticals to host conference call » 16:17 04/14/21 04/14 16:17 04/14/21 16:17 JAZZ Jazz Pharmaceuticals $166.47 / +3.16 (+1.93%) Management holds a… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events JAZZ Jazz Pharmaceuticals $166.47 / +3.16 (+1.93%) 04/12/21 Jazz Pharmaceuticals: FDA grants Priority Review of sNDA for Xywav 04/01/21 Lava Therapeutics appoints Karen Wilson to board of directors 03/30/21 Jazz announces FDA approved revised label for Vyxeos 02/16/21 Jazz completes rolling submission for sNDA to FDA for Xywav oral solution JAZZ Jazz Pharmaceuticals $166.47 / +3.16 (+1.93%) 08:12 Today Stifel Jazz Pharmaceuticals price target raised to $202 from $195 at Stifel 04/06/21 RBC Capital Jazz Pharmaceuticals transferred with an Outperform at RBC Capital 04/01/21 Morgan Stanley Jazz Pharmaceuticals price target raised to $176 from $162 at Morgan Stanley 03/01/21 UBS Jazz Pharmaceuticals price target raised to $228 from $174 at UBS JAZZ Jazz Pharmaceuticals $166.47 / +3.16 (+1.93%) 02/23/21 Jazz Pharmaceuticals sees FY21 adjusted EPS $15.65-$16.85, consensus $16.78 02/23/21 Jazz Pharmaceuticals reports Q4 EPS $4.00, consensus $4.20 02/16/21 GW Pharmaceuticals reports Q4 EPS (8c), consensus (60c) 11/02/20 Jazz Pharma narrows FY20 non-GAAP EPS view to $12.20-$13.00 from $11.90-$13.00 JAZZ Jazz Pharmaceuticals $166.47 / +3.16 (+1.93%) 04/05/21 'Failure is the new winning' for Jazz Pharmaceuticals, FFJ says JAZZ Jazz Pharmaceuticals $166.47 / +3.16 (+1.93%) 02/18/21 Rising High: An exclusive talk with multinational cannabis company Clever Leaves 02/11/21 Rising High: An exclusive talk with biotech company Enveric Biosciences 02/03/21 Fly Intel: Wall Street's top stories for Wednesday 02/03/21 Fly Intel: Wall Street's top stories at midday 05/24/21 Global Healthcare Virtual Conference 2021 04/20/21 Jazz Pharmaceuticals - JAZZ 08/12/21 PDFUA Date for Xywav
Earnings	Tegna reports preliminary Q1 EPS 52c, consensus 46c » 16:17 04/14/21 04/14 16:17 04/14/21 16:17 TGNA Tegna $20.43 / +0.115 (+0.57%) Reports Q1 preliminary… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options TGNA Tegna $20.43 / +0.115 (+0.57%) 03/29/21 Tegna raises quarterly dividend by 36% to 9.5c per share 03/18/21 Tegna shareholder Standard General issues letter to board 02/16/21 Jana Partners buys TreeHouse Foods, exits Callaway in Q4 02/10/21 Entercom announces content agreement with Tegna podcast network TGNA Tegna $20.43 / +0.115 (+0.57%) 01/08/21 Barrington Tegna price target raised to $20 from $18 at Barrington 12/16/20 Huber Research Tegna downgraded to Underweight from Overweight at Huber Research 08/11/20 Wells Fargo Tegna upgraded to Overweight from Equal Weight at Wells Fargo 04/16/20 Wells Fargo Tegna price target lowered to $11 from $18 at Wells Fargo TGNA Tegna $20.43 / +0.115 (+0.57%) 03/01/21 Tegna reports Q4 EPS $1.16, consensus $1.12 01/06/21 Tegna sees FY20 revenue $2.93B-$2.94B, consensus $2.91B 01/06/21 Tegna reports preliminary Q4 revenue $932M-$937M, consensus $904.12M 11/09/20 Tegna reports Q3 EPS 59c, consensus 49c TGNA Tegna $20.43 / +0.115 (+0.57%) 03/09/21 Tegna board nominee Adonis Hoffman withdraws, WSJ reports 03/05/21 Standard General invigorates push for Tegna board seats, Bloomberg reports TGNA Tegna $20.43 / +0.115 (+0.57%) 10/15/20 Fly Intel: Pre-market Movers 05/10/21 Tegna - TGNA TGNA Tegna $20.43 / +0.115 (+0.57%) 01/21/21 Early notable gainers among liquid option names on January 21st 10/15/20 Early notable gainers among liquid option names on October 15th
Technical Analysis	NASDAQ market internals summary » 16:17 04/14/21 04/14 16:17 04/14/21 16:17 $NSD NASDAQ Market Internals / + Volume was above average… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Technical Analysis $NSD NASDAQ Market Internals / + 15:17 Today NASDAQ market internals summary 14:17 Today NASDAQ market internals summary 13:17 Today NASDAQ market internals summary 12:17 Today NASDAQ market internals summary

Hot Stocks	Axis Capital sees Q1 pre-tax net loss estimates for catastrophes of $105M-$115M » 16:16 04/14/21 04/14 16:16 04/14/21 16:16 AXS Axis Capital $52.70 / +0.56 (+1.07%) Axis Capital announced a… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events AXS Axis Capital $52.70 / +0.56 (+1.07%) 01/19/21 Axis Capital announces preliminary Q4 claims estimate of $195M-$205M 12/03/20 Axis Capital raises quarterly dividend 2.4% to 42c per share AXS Axis Capital $52.70 / +0.56 (+1.07%) 03/29/21 Deutsche Bank Axis Capital price target raised to $52 from $46 at Deutsche Bank 01/07/21 BofA Axis Capital downgraded to Underperform from Neutral at BofA 11/27/20 MKM Partners Axis Capital price target raised to $65 from $55 at MKM Partners 11/03/20 Deutsche Bank Axis Capital price target raised to $44 from $42 at Deutsche Bank AXS Axis Capital $52.70 / +0.56 (+1.07%) 01/27/21 Axis Capital reports Q4 operating EPS (20c), consensus (40c) 10/28/20 Axis Capital reports Q3 operating EPS (77c), consensus (48c) 04/29/21 Axis Capital - AXS
Technical Analysis	NYSE market internals summary » 16:16 04/14/21 04/14 16:16 04/14/21 16:16 $NYE NYSE Market Internals / + Volume was average for… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Technical Analysis $NYE NYSE Market Internals / + 15:16 Today NYSE market internals summary 14:16 Today NYSE market internals summary 13:16 Today NYSE market internals summary 12:16 Today NYSE market internals summary
Hot Stocks	Regenxbio says first patient dosed in Cohort 3 of Phase I/II trial of RGX-121 » 16:15 04/14/21 04/14 16:15 04/14/21 16:15 RGNX Regenxbio $35.35 / +0.82 (+2.37%) Regenxbio announced that… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Events RGNX Regenxbio $35.35 / +0.82 (+2.37%) 03/01/21 Regenxbio expects cash to fund operations into second half of 2023 02/16/21 Regenxbio announces additional interim Phase I/IIa data of RGX-314 02/08/21 Regenxbio says interim data shows RGX-121 continues to be well-tolerated 01/05/21 Regenxbio: Pivotal program for RGX-314 for treatment of wet AMD now active RGNX Regenxbio $35.35 / +0.82 (+2.37%) 04/05/21 Morgan Stanley Regenxbio AAV9 patent challenged by Passage Bio, says Morgan Stanley 02/09/21 Morgan Stanley Sarepta denied motion to dismiss 'Wilson Wolf' case, says Morgan Stanley 01/20/21 RBC Capital Regenxbio price target raised to $50 from $42 at RBC Capital 01/06/21 Chardan Regenxbio named top 2021 pick with $100 target at Chardan RGNX Regenxbio $35.35 / +0.82 (+2.37%) 03/01/21 Regenxbio reports Q4 EPS ($1.24), consensus (43c) 08 Jan RGNX Regenxbio $35.35 / +0.82 (+2.37%) 01/06/21 Fly Intel: After-Hours Movers 05/24/21 Global Healthcare Virtual Conference 2021
Hot Stocks	Rise Education reports new and total enrollment at end of Q1 » 16:14 04/14/21 04/14 16:14 04/14/21 16:14 REDU Rise Education $3.45 / +0.04 (+1.17%) Rise Education announced… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings REDU Rise Education $3.45 / +0.04 (+1.17%) 11/23/20 Rise Education CFO Jiandong Lu resigns, Warren Wang to succeed REDU Rise Education $3.45 / +0.04 (+1.17%) 05/18/20 Credit Suisse Rise Education upgraded to Outperform from Neutral at Credit Suisse REDU Rise Education $3.45 / +0.04 (+1.17%) 11/12/20 Rise Education sees Q4 revenue of RMB 355M to RMB 365M 11/12/20 Rise Education reports Q3 non-GAAP EPS 63c vs. 85c a year ago
Hot Stocks	Dell Technologies jumps 8% to $100.40 after planned VMware spin-off » 16:11 04/14/21 04/14 16:11 04/14/21 16:11 DELL Dell Technologies $92.72 / +0.18 (+0.19%) , VMW VMware $155.48 / +1.24 (+0.80%) VMware is up 1.5% to… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options DELL VMW DELL Dell Technologies $92.72 / +0.18 (+0.19%) 16:08 Today Dell Technologies announces planned VMware spin-off 16:05 Today Dell Technologies announces planned VMware spin-off 02/16/21 Elliott buys Evergy, exits eBay in Q4 11/24/20 Dell Technologies reports Q3 Infrastructure Solutions Group revenue $8B VMW VMware $155.48 / +1.24 (+0.80%) 16:08 Today Dell Technologies announces planned VMware spin-off 16:05 Today Dell Technologies announces planned VMware spin-off 04/05/21 VMware COO sells 30.8K shares of common stock 02/10/21 Accenture and VMware extend relationship with dedicated business group DELL VMW DELL Dell Technologies $92.72 / +0.18 (+0.19%) 04/13/21 Morgan Stanley IT hardware analyst to hold analyst/industry conference call 04/08/21 Morgan Stanley Dell Technologies price target raised to $107 from $98 at Morgan Stanley 04/07/21 Deutsche Bank Dell Technologies price target raised to $100 from $94 at Deutsche Bank 02/26/21 JPMorgan Dell Technologies price target raised to $98 from $90 at JPMorgan VMW VMware $155.48 / +1.24 (+0.80%) 04/08/21 BofA VMware reinstated with a Neutral at BofA 04/08/21 BofA VMware reinstated with a Neutral at BofA 03/15/21 Credit Suisse VMware assumed with a Neutral at Credit Suisse 03/03/21 Citi VMware assumed with a Buy at Citi DELL VMW DELL Dell Technologies $92.72 / +0.18 (+0.19%) 02/25/21 Dell Technologies reports Q4 adjusted EPS $2.70, consensus $2.14 02/25/21 Notable companies reporting after market close 11/24/20 Dell Technologies sees Q4 revenue up 3%-4% sequentially, consensus $23.09B 11/24/20 Dell Technologies reports Q3 adjusted EPS $2.03, consensus $1.40 VMW VMware $155.48 / +1.24 (+0.80%) 02/25/21 VMware sees FY22 EPS $6.68, consensus $6.95 02/25/21 VMware sees Q1 EPS $1.49, consensus $1.48 02/25/21 VMware reports Q4 EPS $2.21, consensus $2.05 02/25/21 Notable companies reporting after market close DELL VMW DELL Dell Technologies $92.72 / +0.18 (+0.19%) 03/15/21 Alienware ends Riot esports sponsorship amid harassment claims, Dot Esports says 02/04/21 Boeing to outsource IT work to Dell, slash 600 jobs, AP reports VMW VMware $155.48 / +1.24 (+0.80%) 01/13/21 Intel CEO Swan stepping down, WMware CEO Gelsinger to replace him, CNBC says 01/13/21 Intel CEO Swan to be replaced by VMware's Pat Gelsinger, CNBC reports 01/13/21 Intel CEO Bob Swan to step down, to be replaced by Gelsinger, CNBC reports 12/21/20 Tech giants join Facebook's legal battle against Israel's NSO, Reuters says DELL VMW DELL Dell Technologies $92.72 / +0.18 (+0.19%) 03/16/21 Game On: NPD says February game spending jumped 35% y/y 02/02/21 Dell, Palo Alto upgrades among today's top calls on Wall Street 01/13/21 VMware slides as Gelsinger returns to Intel to be new CEO 11/25/20 Fly Intel: Wall Street's top stories for Wednesday VMW VMware $155.48 / +1.24 (+0.80%) 04/08/21 Adobe coverage reinstatement, Carvana initiation among top calls on Wall Street 03/03/21 Roku upgrade, Coinbase initiation among today's top calls on Wall Street 02/25/21 Fly Intel: After-Hours Movers 02/02/21 Dell, Palo Alto upgrades among today's top calls on Wall Street 05/27/21 Dell Technologies - DELL DELL VMW DELL Dell Technologies $92.72 / +0.18 (+0.19%) 10/26/20 Dell Technologies put volume heavy and directionally bearish VMW VMware $155.48 / +1.24 (+0.80%) 12/18/20 VMware put volume heavy and directionally bearish 10/27/20 Largest borrow rate increases among liquid names 10/26/20 VMware put volume heavy and directionally bearish

Hot Stocks	InspireMD announces 1-for-15 reverse stock split » 16:10 04/14/21 04/14 16:10 04/14/21 16:10 NSPR InspireMD / + InspireMD announced a… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate NSPR InspireMD / + 03/22/21 InspireMD CEO urges stockholders to support plans to list on Nasdaq 02/24/21 InspireMD engages Hart Clinical Consultants for CGuard stent system trial 02/03/21 InspireMD secures partner for intended distribution of CGuard EPS in China 11/03/20 InspireMD appoints Andrea Tommasoli as SVP, global sales and marketing NSPR InspireMD / + 10/16/20 Alliance Global Partners InspireMD initiated with a Buy at Alliance Global Partners NSPR InspireMD / + 11/09/20 InspireMD reports Q3 EPS (6c), consensus (18c) 04 Feb
Initiation	Elanco initiated with a Buy at Stifel » 16:09 04/14/21 04/14 16:09 04/14/21 16:09 ELAN Elanco $29.54 / +0.175 (+0.60%) Stifel analyst Jonathan… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Events Options ELAN Elanco $29.54 / +0.175 (+0.60%) 03/19/21 Elanco reiterates it 'stands behind the safety data of Seresto' 03/03/21 Elanco off lows, turns positive after WSJ report of Starboard board nominations 02/25/21 Kindred submits efficacy data to support prophylactic indication for KIND-030 02/25/21 Apria names Michael-Bryant Hicks as EVP, general counsel ELAN Elanco $29.54 / +0.175 (+0.60%) 03/22/21 Fly Intel: Top five analyst downgrades 03/22/21 Gabelli Elanco downgraded to Hold from Buy at Gabelli 03/08/21 Citi Elanco price target raised to $39 from $35 at Citi 02/26/21 Barclays Judge allows challenge to Elanco's Experior, says Barclays ELAN Elanco $29.54 / +0.175 (+0.60%) 02/24/21 Elanco raises FY21 adjusted EPS view to 90c-$1.00 from 83c-95c, consensus 91c 02/24/21 Elanco sees Q1 adjusted EPS 20c-25, consensus 22c 02/24/21 Elanco reports Q4 adjusted EPS 12c, consensus 9c 02/23/21 Notable companies reporting before tomorrow's open 01 Dec ELAN Elanco $29.54 / +0.175 (+0.60%) 03/29/21 Starboard withdrew Elanco board nominations earlier this month, Reuters reports 03/29/21 Starboard withdrew Elanco board nominations, Reuters reports 03/03/21 Starboard takes Elanco stake, nominates three to board, WSJ reports 03/03/21 Activist Starboard takes stake in Elanco, makes board nominations, WSJ says ELAN Elanco $29.54 / +0.175 (+0.60%) 03/03/21 Fly Intel: Wall Street's top stories for Wednesday 02/24/21 Fly Intel: Pre-market Movers 11/09/20 Biogen downgrade, Fisker initiation among today's top calls on Wall Street 11/06/20 Fly Intel: Pre-market Movers 05/07/21 Elanco - ELAN 05/19/21 Elanco Animal Health, Inc. ELAN Elanco $29.54 / +0.175 (+0.60%) 12/14/20 Elanco Animal Health call volume above normal and directionally bullish 11/27/20 Elanco Animal Health put volume heavy and directionally bearish
Earnings	Harrow Health sees Q1 revenue $14.9M-$15.5M,consensus $13.66M » 16:08 04/14/21 04/14 16:08 04/14/21 16:08 HROW Harrow Health $6.79 / -0.03 (-0.44%) Sees Q1 adjusted EBITDA… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research HROW Harrow Health $6.79 / -0.03 (-0.44%) 12/03/20 Harrow Health announces publication of study on MKO Melt formulation HROW Harrow Health $6.79 / -0.03 (-0.44%) 01/04/21 B. Riley Securities Harrow Health price target raised to $14 from $12 at B. Riley Securities
Hot Stocks	Dell Technologies announces planned VMware spin-off » 16:08 04/14/21 04/14 16:08 04/14/21 16:08 DELL Dell Technologies $92.75 / +0.21 (+0.23%) , VMW VMware $155.87 / +1.63 (+1.06%) Dell Technologies (DELL)… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options DELL VMW DELL Dell Technologies $92.75 / +0.21 (+0.23%) 16:05 Today Dell Technologies announces planned VMware spin-off 02/16/21 Elliott buys Evergy, exits eBay in Q4 11/24/20 Dell Technologies reports Q3 Infrastructure Solutions Group revenue $8B 11/24/20 Dell Technologies reports Q3 Client Solutions Group revenue $12.3B VMW VMware $155.87 / +1.63 (+1.06%) 16:05 Today Dell Technologies announces planned VMware spin-off 04/05/21 VMware COO sells 30.8K shares of common stock 02/10/21 Accenture and VMware extend relationship with dedicated business group 02/03/21 Lumen and VMware expand partnership and delivery of edge computing DELL VMW DELL Dell Technologies $92.75 / +0.21 (+0.23%) 04/13/21 Morgan Stanley IT hardware analyst to hold analyst/industry conference call 04/08/21 Morgan Stanley Dell Technologies price target raised to $107 from $98 at Morgan Stanley 04/07/21 Deutsche Bank Dell Technologies price target raised to $100 from $94 at Deutsche Bank 02/26/21 JPMorgan Dell Technologies price target raised to $98 from $90 at JPMorgan VMW VMware $155.87 / +1.63 (+1.06%) 04/08/21 BofA VMware reinstated with a Neutral at BofA 04/08/21 BofA VMware reinstated with a Neutral at BofA 03/15/21 Credit Suisse VMware assumed with a Neutral at Credit Suisse 03/03/21 Citi VMware assumed with a Buy at Citi DELL VMW DELL Dell Technologies $92.75 / +0.21 (+0.23%) 02/25/21 Dell Technologies reports Q4 adjusted EPS $2.70, consensus $2.14 02/25/21 Notable companies reporting after market close 11/24/20 Dell Technologies sees Q4 revenue up 3%-4% sequentially, consensus $23.09B 11/24/20 Dell Technologies reports Q3 adjusted EPS $2.03, consensus $1.40 VMW VMware $155.87 / +1.63 (+1.06%) 02/25/21 VMware sees FY22 EPS $6.68, consensus $6.95 02/25/21 VMware sees Q1 EPS $1.49, consensus $1.48 02/25/21 VMware reports Q4 EPS $2.21, consensus $2.05 02/25/21 Notable companies reporting after market close DELL VMW DELL Dell Technologies $92.75 / +0.21 (+0.23%) 03/15/21 Alienware ends Riot esports sponsorship amid harassment claims, Dot Esports says 02/04/21 Boeing to outsource IT work to Dell, slash 600 jobs, AP reports VMW VMware $155.87 / +1.63 (+1.06%) 01/13/21 Intel CEO Swan stepping down, WMware CEO Gelsinger to replace him, CNBC says 01/13/21 Intel CEO Swan to be replaced by VMware's Pat Gelsinger, CNBC reports 01/13/21 Intel CEO Bob Swan to step down, to be replaced by Gelsinger, CNBC reports 12/21/20 Tech giants join Facebook's legal battle against Israel's NSO, Reuters says DELL VMW DELL Dell Technologies $92.75 / +0.21 (+0.23%) 03/16/21 Game On: NPD says February game spending jumped 35% y/y 02/02/21 Dell, Palo Alto upgrades among today's top calls on Wall Street 01/13/21 VMware slides as Gelsinger returns to Intel to be new CEO 11/25/20 Fly Intel: Wall Street's top stories for Wednesday VMW VMware $155.87 / +1.63 (+1.06%) 04/08/21 Adobe coverage reinstatement, Carvana initiation among top calls on Wall Street 03/03/21 Roku upgrade, Coinbase initiation among today's top calls on Wall Street 02/25/21 Fly Intel: After-Hours Movers 02/02/21 Dell, Palo Alto upgrades among today's top calls on Wall Street 05/27/21 Dell Technologies - DELL DELL VMW DELL Dell Technologies $92.75 / +0.21 (+0.23%) 10/26/20 Dell Technologies put volume heavy and directionally bearish VMW VMware $155.87 / +1.63 (+1.06%) 12/18/20 VMware put volume heavy and directionally bearish 10/27/20 Largest borrow rate increases among liquid names 10/26/20 VMware put volume heavy and directionally bearish
Earnings	Ethan Allen reports preliminary Q3 adjusted EPS 56c-58c, two estimates 47c » 16:07 04/14/21 04/14 16:07 04/14/21 16:07 ETH Ethan Allen $27.57 / +0.1 (+0.36%) Reports preliminary Q3… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly ETH Ethan Allen $27.57 / +0.1 (+0.36%) 11/12/20 Ethan Allen increases quarterly cash dividend 19% to 25c per share ETH Ethan Allen $27.57 / +0.1 (+0.36%) 11/24/20 UBS RH price target raised to $450 from $380 at UBS ETH Ethan Allen $27.57 / +0.1 (+0.36%) 01/28/21 Ethan Allen reports Q 2EPS 69c, consensus 68c 01/14/21 Ethan Allen sees Q2 EPS 67c-69c, two estimates 46c 10/29/20 Ethan Allen reports Q1 adjusted EPS 36c, consensus 35c ETH Ethan Allen $27.57 / +0.1 (+0.36%) 01/28/21 Fly Intel: After-Hours Movers 10/29/20 Fly Intel: After-Hours Movers

Hot Stocks	8x8 names Walt Weisner chief customer officer » 16:07 04/14/21 04/14 16:07 04/14/21 16:07 EGHT 8x8 $33.40 / +0.45 (+1.37%) 8x8 announced the… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events EGHT 8x8 $33.40 / +0.45 (+1.37%) 03/04/21 8x8 appoints Amritesh Chaudhuri as chief marketing officer 02/22/21 8x8 awarded NASPO State of Washington contract 01/05/21 8x8 falls -5.2% 12/10/20 8x8 rises 31.3% EGHT 8x8 $33.40 / +0.45 (+1.37%) 01/29/21 Craig-Hallum 8x8 price target raised to $45 from $22 at Craig-Hallum 01/25/21 B. Riley Securities 8x8 price target raised to $32.50 from $25 at B. Riley Securities 01/19/21 BTIG 8x8 price target raised to $44 from $35 at BTIG 01/05/21 Wells Fargo 8x8 downgraded to Underweight from Equal Weight at Wells Fargo EGHT 8x8 $33.40 / +0.45 (+1.37%) 02/16/21 Tiger Global bought DoorDash and 1Life during Q4, sold out of Alphabet 01/28/21 8x8 raises FY21 revenue view from $519M-$522M to $526.1M-$528.1M 01/28/21 8x8 sees Q4 revenue $138.5M-$140.5M, consensus $138.51M 01/28/21 8x8 reports Q3 EPS (2c), consensus (3c) EGHT 8x8 $33.40 / +0.45 (+1.37%) 01/28/21 Fly Intel: After-Hours Movers 01/05/21 Fly Intel: Wall Street's top stories at midday 01/05/21 Fly Intel: Pre-market Movers 10/28/20 Fly Intel: After-Hours Movers 05/24/21 Global Technology, Media & Communications Virtual Conference 06/15/21 Customer Engagement SaaS Virtual Conference
Hot Stocks	AbCellera, Empirico to partner on multi-target antibody discovery » 16:06 04/14/21 04/14 16:06 04/14/21 16:06 ABCL AbCellera $28.37 / +0.04 (+0.14%) AbCellera and Empirico… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Options ABCL AbCellera $28.37 / +0.04 (+0.14%) 04/01/21 AbCellera, Gilead announce new multi-Year, multi-target antibody discovery pact 03/10/21 AbCellera notes 'second positive Phase 3 trial readout' for bamlanivimab combo 02/11/21 AbCellera names Ester Falconer CTO 02/09/21 AbCellera's Bamlanivimab gets FDA EUA for COVID-19 treatment ABCL AbCellera $28.37 / +0.04 (+0.14%) 03/30/21 SVB Leerink AbCellera price target lowered to $45 from $52 at SVB Leerink 03/24/21 BMO Capital AbCellera price target lowered to $59 from $61 at BMO Capital 02/08/21 SVB Leerink AbCellera price target raised to $52 from $45 at SVB Leerink 01/26/21 Berenberg Eli Lilly data 'incrementally positive' for AbCellera, says Berenberg ABCL AbCellera $28.37 / +0.04 (+0.14%) 03/29/21 AbCellera reports FY20 EPS 45c, consensus 60c 11 Dec ABCL AbCellera $28.37 / +0.04 (+0.14%) 04/01/21 Fly Intel: Wall Street's top stories for Thursday 04/01/21 Fly Intel: Wall Street's top stories at midday 03/30/21 Fly Intel: Wall Street's top stories at midday 03/30/21 Fly Intel: Pre-market Movers ABCL AbCellera $28.37 / +0.04 (+0.14%) 04/08/21 Largest borrow rate increases among liquid names 03/17/21 new option listings on March 17th
Hot Stocks	Medavail says North Texas health system expands technology agreement » 16:06 04/14/21 04/14 16:06 04/14/21 16:06 MDVL Medavail $13.36 / -0.28 (-2.05%) MedAvail Holdings… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research On The Fly MDVL Medavail $13.36 / -0.28 (-2.05%) 04/12/21 Cowen Medavail price target raised to $20 from $18 at Cowen 04/05/21 Cowen Medavail price target raised to $18 from $17 at Cowen 12/14/20 Lake Street Medavail initiated with a Buy at Lake Street 12/14/20 Cowen Medavail initiated with an Outperform at Cowen MDVL Medavail $13.36 / -0.28 (-2.05%) 12/21/20 Fly Insider: Net 1 UEPS, GrafTech among weeks notable insider trades
Hot Stocks	Dell Technologies announces planned VMware spin-off 16:05 04/14/21 04/14 16:05 04/14/21 16:05 DELL Dell Technologies $92.78 / +0.24 (+0.26%) , VMW VMware $155.71 / +1.47 (+0.95%) ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options DELL VMW DELL Dell Technologies $92.78 / +0.24 (+0.26%) 02/16/21 Elliott buys Evergy, exits eBay in Q4 11/24/20 Dell Technologies reports Q3 Infrastructure Solutions Group revenue $8B 11/24/20 Dell Technologies reports Q3 Client Solutions Group revenue $12.3B 11/24/20 Dell Technologies reports total deferred revenue of $28.7B at Q3-end VMW VMware $155.71 / +1.47 (+0.95%) 04/05/21 VMware COO sells 30.8K shares of common stock 02/10/21 Accenture and VMware extend relationship with dedicated business group 02/03/21 Lumen and VMware expand partnership and delivery of edge computing 01/13/21 VMware names CFO Rowe interim CEO, board starts search DELL VMW DELL Dell Technologies $92.78 / +0.24 (+0.26%) 04/13/21 Morgan Stanley IT hardware analyst to hold analyst/industry conference call 04/08/21 Morgan Stanley Dell Technologies price target raised to $107 from $98 at Morgan Stanley 04/07/21 Deutsche Bank Dell Technologies price target raised to $100 from $94 at Deutsche Bank 02/26/21 JPMorgan Dell Technologies price target raised to $98 from $90 at JPMorgan VMW VMware $155.71 / +1.47 (+0.95%) 04/08/21 BofA VMware reinstated with a Neutral at BofA 04/08/21 BofA VMware reinstated with a Neutral at BofA 03/15/21 Credit Suisse VMware assumed with a Neutral at Credit Suisse 03/03/21 Citi VMware assumed with a Buy at Citi DELL VMW DELL Dell Technologies $92.78 / +0.24 (+0.26%) 02/25/21 Dell Technologies reports Q4 adjusted EPS $2.70, consensus $2.14 02/25/21 Notable companies reporting after market close 11/24/20 Dell Technologies sees Q4 revenue up 3%-4% sequentially, consensus $23.09B 11/24/20 Dell Technologies reports Q3 adjusted EPS $2.03, consensus $1.40 VMW VMware $155.71 / +1.47 (+0.95%) 02/25/21 VMware sees FY22 EPS $6.68, consensus $6.95 02/25/21 VMware sees Q1 EPS $1.49, consensus $1.48 02/25/21 VMware reports Q4 EPS $2.21, consensus $2.05 02/25/21 Notable companies reporting after market close DELL VMW DELL Dell Technologies $92.78 / +0.24 (+0.26%) 03/15/21 Alienware ends Riot esports sponsorship amid harassment claims, Dot Esports says 02/04/21 Boeing to outsource IT work to Dell, slash 600 jobs, AP reports VMW VMware $155.71 / +1.47 (+0.95%) 01/13/21 Intel CEO Swan stepping down, WMware CEO Gelsinger to replace him, CNBC says 01/13/21 Intel CEO Swan to be replaced by VMware's Pat Gelsinger, CNBC reports 01/13/21 Intel CEO Bob Swan to step down, to be replaced by Gelsinger, CNBC reports 12/21/20 Tech giants join Facebook's legal battle against Israel's NSO, Reuters says DELL VMW DELL Dell Technologies $92.78 / +0.24 (+0.26%) 03/16/21 Game On: NPD says February game spending jumped 35% y/y 02/02/21 Dell, Palo Alto upgrades among today's top calls on Wall Street 01/13/21 VMware slides as Gelsinger returns to Intel to be new CEO 11/25/20 Fly Intel: Wall Street's top stories for Wednesday VMW VMware $155.71 / +1.47 (+0.95%) 04/08/21 Adobe coverage reinstatement, Carvana initiation among top calls on Wall Street 03/03/21 Roku upgrade, Coinbase initiation among today's top calls on Wall Street 02/25/21 Fly Intel: After-Hours Movers 02/02/21 Dell, Palo Alto upgrades among today's top calls on Wall Street 05/27/21 Dell Technologies - DELL DELL VMW DELL Dell Technologies $92.78 / +0.24 (+0.26%) 10/26/20 Dell Technologies put volume heavy and directionally bearish VMW VMware $155.71 / +1.47 (+0.95%) 12/18/20 VMware put volume heavy and directionally bearish 10/27/20 Largest borrow rate increases among liquid names 10/26/20 VMware put volume heavy and directionally bearish
Conference/Events	Alnylam to host conference call » 16:05 04/14/21 04/14 16:05 04/14/21 16:05 ALNY Alnylam $138.94 / +3.02 (+2.22%) Management holds a… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals Events ALNY Alnylam $138.94 / +3.02 (+2.22%) 04/11/21 Alnylam presents late-breaking data from ongoing Phase 1 study of ALN-AGT 04/08/21 Royalty Pharma acquires OXLUMO royalty interest from Dicerna for up to $240M 04/08/21 Royalty Pharma acquires Oxlumo royalty interest from Dicerna for $180M upfront 03/31/21 Alnylam announces NEJM publication of phase3 study of lumasiran in PH1 treatment ALNY Alnylam $138.94 / +3.02 (+2.22%) 02/22/21 Guggenheim Alnylam downgraded to Neutral from Buy at Guggenheim 02/12/21 Fly Intel: Top five analyst downgrades 02/12/21 Barclays Alnylam price target raised to $196 from $162 at Barclays 02/12/21 Citi Alnylam downgraded to Neutral from Buy at Citi ALNY Alnylam $138.94 / +3.02 (+2.22%) 02/11/21 Alnylam sees FY21 product revenue $610M-$660M 02/11/21 Alnylam reports Q4 non-GAAP EPS ($1.60), consensus ($1.76) 11/05/20 Alnylam reports Q3 EPS ($1.58), consensus ($1.66) ALNY Alnylam $138.94 / +3.02 (+2.22%) 11/23/20 Alnylam gets FDA approval for Oxlumo, Bloomberg reports 05/24/21 Global Healthcare Virtual Conference 2021 05/18/21 Alnylam Pharmaceuticals Inc.

Hot Stocks	CoStar Group to acquire Homes.com for $156M » 16:05 04/14/21 04/14 16:05 04/14/21 16:05 CSGP CoStar Group $892.36 / -14.57 (-1.61%) CoStar Group announced … Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Events CSGP CoStar Group $892.36 / -14.57 (-1.61%) 03/25/21 Atotech appoints Sarah Spray as global head of IR, communications 03/09/21 CoStar Group to expand footprint in Richmond, Virginia 03/04/21 CoStar withdraws bid to acquire CoreLogic, ends further acquisition talks 03/04/21 CoStar to pay RentPath $52M in settlement of break-up fee litigation CSGP CoStar Group $892.36 / -14.57 (-1.61%) 03/15/21 Goldman Sachs CoStar Group reinstated with a Buy at Goldman Sachs 03/05/21 Keefe Bruyette CoStar decision to walk removes overhang on shares, says Keefe Bruyette 02/04/21 Stephens CoreLogic accepting $80 bid 'a bit of an odd twist,' says Stephens 12/22/20 JMP Securities RealPage price target raised to $101 from $80 at JMP Securities CSGP CoStar Group $892.36 / -14.57 (-1.61%) 02/23/21 CoStar Group sees FY21 EPS $10.83-$11.03, consensus $11.42 02/23/21 CoStar Group sees Q1 EPS $2.33-$2.43, consensus $2.64 02/23/21 CoStar Group reports Q4 EPS $2.85, consensus $2.41 10/27/20 CoStar Group sees FY20 EPS $9.39-$9.49, consensus $9.36 21 May CSGP CoStar Group $892.36 / -14.57 (-1.61%) 02/25/21 CoreLogic asks CoStar for more assurances on antitrust risk, Reuters reports 02/04/21 CoStar studying CoreLogic options, including possible new bid, WSJ says 02/04/21 CoStar considering new bid for CoreLogic, WSJ says 02/04/21 CoreLogic sold to private equity for $80 per share, CNBC's Faber reports CSGP CoStar Group $892.36 / -14.57 (-1.61%) 03/15/21 ViacomCBS downgrade, MGM Resorts upgrade among today's top calls on Wall Street 02/23/21 Fly Intel: After-Hours Movers 02/16/21 Fly Intel: Wall Street's top stories for Tuesday 02/16/21 Fly Intel: Wall Street's top stories at midday 05/24/21 Global Technology, Media & Communications Virtual Conference 04/27/21 CoStar Group - CSGP
Hot Stocks	Becton Dickinson's Pristine hemodialysis catheter granted 510(k) clearance » 16:04 04/14/21 04/14 16:04 04/14/21 16:04 BDX Becton Dickinson $249.80 / -0.92 (-0.37%) Becton Dickinson has… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Events BDX Becton Dickinson $249.80 / -0.92 (-0.37%) 04/13/21 Becton Dickinson announces BD MAX MDR-TB assay recognized for accuracy by WHO 04/07/21 Inogen appoints George Parr as Chief Commercial Officer 04/01/21 Becton Dickinson to invest $65M to construct Arizona supply chain facility 04/01/21 Becton Dickinson receives EUA from FDA for rapid antigen test BDX Becton Dickinson $249.80 / -0.92 (-0.37%) 04/05/21 Argus Weaker demand for Covid testing solutions to weigh on BD, says Argus 04/01/21 Piper Sandler Integra to benefit from FDA safety communication, says Piper Sandler 02/12/21 Wells Fargo Wells Fargo sees only 'small chance' of positive FDA panel for Becton 02/05/21 Citi Becton Dickinson price target raised to $280 from $273 at Citi BDX Becton Dickinson $249.80 / -0.92 (-0.37%) 02/04/21 Becton Dickinson raises FY21 adj. EPS view to $12.75-$12.85 from $12.40-$12.60 02/04/21 Becton Dickinson reports Q1 adjusted EPS $4.55, consensus $3.11 02/03/21 Notable companies reporting before tomorrow's open 02/03/21 Notable companies reporting before tomorrow's open 21 May BDX Becton Dickinson $249.80 / -0.92 (-0.37%) 02/04/21 Fly Intel: Pre-market Movers 05/24/21 Global Healthcare Virtual Conference 2021 05/06/21 Becton Dickinson - BDX
Hot Stocks	Pacira seeks court injunction to protect clinical integrity of Exparel » 16:04 04/14/21 04/14 16:04 04/14/21 16:04 PCRX Pacira $69.31 / +1.15 (+1.69%) Pacira BioSciences filed… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings PCRX Pacira $69.31 / +1.15 (+1.69%) 04/07/21 Pacira reports preliminary Q1 net product sales $118.7M, consensus $119.19M 03/22/21 Pacira says FDA approves supplemental NDA for EXPAREL in pediatric patients 03/09/21 Pacira reports preliminary sales of $36.2 for February 02/25/21 Pacira reports Q4 EXPAREL net product sales up 7% to $125.3M PCRX Pacira $69.31 / +1.15 (+1.69%) 04/09/21 Berenberg Pacira initiated with a Buy at Berenberg 04/06/21 RBC Capital Pacira transferred with an Outperform at RBC Capital 03/01/21 H.C. Wainwright Pacira price target raised to $86 from $70 at H.C. Wainwright 02/26/21 Barclays Pacira price target raised to $94 from $79 at Barclays PCRX Pacira $69.31 / +1.15 (+1.69%) 02/25/21 Pacira reports Q4 adjusted EPS 87c, consensus 81c 01/07/21 Pacira reports 2020 revenue $429.6M, consensus $427.7M 10/29/20 Pacira reports Q3 adj. EPS 68c, consensus 63c
Hot Stocks	Steven Madden acquires 49.9% share of JV not already owned, terms undisclosed » 16:03 04/14/21 04/14 16:03 04/14/21 16:03 SHOO Steven Madden $38.49 / +0.32 (+0.84%) Steven Madden announced… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events SHOO Steven Madden $38.49 / +0.32 (+0.84%) 12/10/20 Steven Madden appoints Zine Mazouzi as CFO effective January 1 10/27/20 Steven Madden not providing guidance SHOO Steven Madden $38.49 / +0.32 (+0.84%) 02/26/21 B. Riley Securities Steven Madden price target raised to $44 from $40 at B. Riley Securities 01/27/21 Citi Steven Madden price target raised to $35 from $29 at Citi 12/10/20 B. Riley Securities Steven Madden price target raised to $40 from $34 at B. Riley Securities 12/09/20 Loop Capital Steven Madden price target raised to $35 from $25 at Loop Capital SHOO Steven Madden $38.49 / +0.32 (+0.84%) 02/25/21 Steven Madden reports Q4 adjusted EPS 27c, consensus 21c 10/27/20 Steven Madden reports Q3 adjusted EPS 39c, consensus 21c 04/28/21 Steven Madden - SHOO 05/26/21 Steven Madden Ltd
Hot Stocks	PPD trading resumes 16:00 04/14/21 04/14 16:00 04/14/21 16:00 PPD PPD $38.97 / +0.62 (+1.62%) ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Events PPD PPD $38.97 / +0.62 (+1.62%) 15:47 Today PPD trading halted, volatility trading pause 04/13/21 AzurRx BioPharma partners with PPD for clinical trial for niclosamide 04/06/21 AzurRx BioPharma initiates Phase 2 clinical trial of niclosamide 03/24/21 PPD, Clinical Ink team on process for lupus assessment PPD PPD $38.97 / +0.62 (+1.62%) 03/02/21 Barclays PPD initiated with an Overweight at Barclays 03/02/21 Barclays PPD initiated with an Overweight at Barclays 02/25/21 Deutsche Bank PPD price target raised to $39 from $38 at Deutsche Bank 02/25/21 Citi PPD price target raised to $42 from $40 at Citi PPD PPD $38.97 / +0.62 (+1.62%) 02/23/21 PPD sees 2021 adjusted EPS $1.37-$1.45, consensus $1.39 02/23/21 PPD sees Q1 adjusted EPS 30c-32c, consensus 32c 02/23/21 PPD reports Q4 adjusted EPS 39c, consensus 36c 10/27/20 PPD sees Q4 revenue $1.26B-$1.3B, consensus $1.15B 17 Sep PPD PPD $38.97 / +0.62 (+1.62%) 15:51 Today Thermo Fisher near deal to buy PPD for over $15B, WSJ reports 15:49 Today PPD jumps 13% after report of Thermo Fisher takeover talks PPD PPD $38.97 / +0.62 (+1.62%) 03/15/21 Meet AzurRx BioPharma: A Fly exclusive interview with CEO James Sapirstein 04/28/21 PPD - PPD 04/23/21 PPD, Inc.

Events

Earnings calls, analyst events, roadshows and more

BRFH
Today at 16:30

Barfresh Food Group - BRFH Conference Calls
Today at 18:05

Fed Reserve Bank President Participates in Virtual Event Government Event

Virtual Event
GHG
Today at 21:00

GreenTree Hospitality - GHG Conference Calls
AKYA
Tomorrow at 00:00

Akoya Biosciences - AKYA Syndicate Roadshows

Virtual Meeting
BMEA
Tomorrow at 00:00

Biomea Fusion - BMEA Syndicate Roadshows

Virtual Meeting
COO
Tomorrow at 00:00

Cooper Companies - COO Conference Calls
VNRX
Tomorrow at 00:00

VolitionRx - VNRX Conference Calls
VERI
Tomorrow at 00:00

Veritone - VERI Conference Calls
KRKNF ...
Tomorrow at 00:00

Technology Investor Virtual Conference Conferences
Tomorrow at 00:00

KeyBank Executive Virtual Roundtable Conferences

Virtual Roundtable

View All Events »

1 of

Syndicate

This week’s upcoming IPOs and secondary offerings

Priced
Not Priced

Mon	CHWY X CHWY Chewy Block Trade Managers: Morgan Stanley Priced at: $82.50 6.1M Shares EPRT X EPRT Essential Properties Realty Trust Spot Secondary Managers: Citi, BofA & Barclays Priced at: $23.50 7.15M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial GFL X GFL GFL Environmental Spot Secondary Managers: BMO Capital, RBC Capital & Scotiabank Priced at: $33.95 17.5M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Tues	DISCA X DISCA Discovery Block Trade Managers: Credit Suisse Priced at: $38.40 19M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial DISCK X DISCK Discovery Inc. Block Trade Managers: Credit Suisse Priced at: $32.35 22M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial IQ X IQ iQIYI Block Trade Managers: Credit Suisse Priced at: $15.85 35M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ALKT X ALKT Alkami IPO Managers: Goldman Sachs, JPMorgan & Barclays, Citi, William Blair, JMP Securities, KeyBanc, Needham Priced at: $30.00 6M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Wed	No deals
Thurs	No deals
Fri	No deals

Mon	No deals
Tues	No deals
Wed	COIN X COIN Coinbase Direct Listing Managers: Direct Listing $250 Reference Price 114.851M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial AGL X AGL Agilon Health IPO Managers: JPMorgan, Goldman Sachs & BofA, Deutsche Bank, Wells Fargo, William Blair, Truist, Nomura $20.00-23.00 46.6M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial APP X APP AppLovin IPO Managers: Morgan Stanley, JPMorgan, KKR, BofA & Citi, Credit Suisse, UBS, Oppenheimer, Stifel, Truist, William Blair, Truist, Luma, Guzman & Company, LionTree Advisors, The Raine Group, Blaylock Van, R. Seelaus $75.00-85.00 25M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial EBET X EBET Esports Technologies IPO Managers: Boustead $5.00-6.00 2M Shares KRT X KRT Karat Packaging IPO Managers: Stifel, William Blair & Truist, National Securities, DA Davidson $18.00-20.00 3.95M Shares TSP X TSP TuSimple IPO Managers: Morgan Stanley, Citi & JPMorgan, BofA, Cowen, Credit Suisse, Nomura, RBC Capital, Baird, Needham, Oppenheimer, Piper Sandler, Valuable Capital $35.00-39.00 33.784M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Thurs	AKYA X AKYA Akoya Biosciences IPO Managers: JPMorgan, Morgan Stanley, Piper Sandler & Canaccord $18.00-20.00 6.58M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial BMEA X BMEA Biomea Fusion IPO Managers: JPMorgan, Jefferies & Piper Sandler $15.00-17.00 7.5M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial RXRX X RXRX Recursion Pharmaceuticals IPO Managers: Goldman Sachs & JPMorgan, BofA, SVB Leerink, Allen & Co., KeyBanc $16.00-18.00 18M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial BALY X BALY Bally's Secondary Managers: Deutsche Bank, Goldman Sachs & Barclays $60.80 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial NRZ X NRZ New Residential Secondary Managers: SBHS $10.94 45M Shares
Fri	No deals

View All Syndicate Announcements »

NASDAQ market internals summary

TODAY'S FREE FLY STORIES

Get Full Fly Access